These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis. Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382 [TBL] [Abstract][Full Text] [Related]
7. Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Hervonen K; Alakoski A; Salmi TT; Helakorpi S; Kautiainen H; Kaukinen K; Pukkala E; Collin P; Reunala T Br J Dermatol; 2012 Dec; 167(6):1331-7. PubMed ID: 22708883 [TBL] [Abstract][Full Text] [Related]
8. Quality of Life and Gastrointestinal Symptoms in Long-Term Treated Dermatitis Herpetiformis Patients: A Cross-Sectional Study in Finland. Pasternack C; Kaukinen K; Kurppa K; Mäki M; Collin P; Reunala T; Huhtala H; Salmi T Am J Clin Dermatol; 2015 Dec; 16(6):545-52. PubMed ID: 26267424 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal Symptoms Increase the Burden of Illness in Dermatitis Herpetiformis: A Prospective Study. Pasternack C; Kaukinen K; Kurppa K; Mäki M; Collin P; Hervonen K; Reunala T; Huhtala H; Kekkonen L; Salmi T Acta Derm Venereol; 2017 Jan; 97(1):58-62. PubMed ID: 27241271 [TBL] [Abstract][Full Text] [Related]